Circulating soluble leptin receptor, leptin, and insulin resistance before and after weight loss in obese children

T Reinehr1, J Kratzsch, W Kiess

  • 1Vestische Hospital for Children and Adolescents Datteln, University of Witten/Herdecke, Germany. T.Reinehr@kinderklinik-datteln.de

Insights

In obese children, lower soluble leptin receptor (sOB-R) and higher leptin levels normalized after weight loss, indicating they are consequences, not causes, of obesity. Leptin levels, unlike sOB-R, are linked to insulin resistance.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Syndrome Research
  • Obesity and Weight Management

Background:

  • Obesity in children is associated with hormonal imbalances, including leptin and its soluble receptor (sOB-R).
  • Insulin resistance is a key metabolic complication often observed in pediatric obesity.

Purpose of the Study:

  • To investigate the dynamic relationship between leptin, sOB-R, and insulin resistance (Homeostasis Model Assessment - HOMA) in obese children.
  • To determine if changes in leptin and sOB-R precede or follow weight reduction and alterations in insulin sensitivity.

Main Methods:

  • Fasting serum leptin, sOB-R, and HOMA were measured in 36 obese children and 72 lean controls at baseline and after 1 year.
  • Changes in leptin (Deltaleptin), sOB-R (DeltasOB-R), and HOMA (DeltaHOMA) were correlated with changes in BMI (DeltaBMI) and body fat percentage (Delta%BF).
  • Multiple linear regression analyses and comparisons between weight-losing and non-weight-losing obese children were performed.

Main Results:

  • Obese children exhibited higher leptin and lower sOB-R levels compared to lean controls.
  • Deltaleptin significantly correlated with Delta%BF and DeltaHOMA, while DeltasOB-R correlated with Delta%BF but not DeltaHOMA.
  • Substantial weight loss in obese children led to significant increases in sOB-R and decreases in HOMA, while leptin levels normalized.

Conclusions:

  • The observed changes in leptin and sOB-R in obese children appear to be consequences, not causes, of excess weight.
  • Leptin levels are significantly associated with insulin resistance (HOMA) in pediatric obesity, unlike sOB-R.
  • Weight reduction interventions can positively impact sOB-R levels and improve insulin sensitivity in obese children.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...